Fuss Brands Corp

Fuss Brands Corp. (OTC: FBDS), incorporated in 1988 and headquartered in New York, New York, is a public shell company that previously operated under the name China Botanic Pharmaceutical Inc. before changing its name to Fuss Brands Corp. in July 2022. The company presently does not have significant ongoing operations and is actively evaluating business opportunities in the United States, including the potential acquisition of an operating business through a reverse merger, asset purchase, or similar strategic transaction. This acquisition-focused posture is typical of OTC-listed shell companies that retain their public company structure as a vehicle for facilitating transactions with private operating businesses seeking public market access.<br><br>Fuss Brands Corp. holds marketing and distribution rights for a patented range of convertible luggage products, including a regulation-size carry-on bag that converts into a full-sized suitcase — a product designed to address the needs of travelers who face airline carry-on restrictions while also requiring larger checked-baggage capacity. The company also has rights to a compact laptop bag in the same product family. These intellectual property and distribution rights represent the company's primary current commercial assets, though they have not generated significant revenue in recent reporting periods, and the company's primary strategic direction remains the identification of a business combination target.<br><br>Fuss Brands Corp. trades on OTC Markets under the ticker symbol FBDS and maintains its SEC reporting obligations, filing quarterly 10-Q reports that document its financial condition, business development activities, and evaluation of acquisition opportunities. With a market capitalization of approximately $2.2 million and a stock price near $0.10 per share, the company occupies the penny stock segment of OTC Markets and is subject to the SEC's penny stock rules for transactions in its shares. The company's long operating history and retained public company status provide a foundation for a potential reverse merger with a qualifying private operating business seeking to access U.S. public capital markets.